These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 577918)
1. Factors affecting the bioavailability of phenytoin. Neuvonen PJ; Pentikäinen PJ; Elfving SM Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):84-9. PubMed ID: 577918 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of four brands of phenytoin tablets. Pentikäinen PJ; Neuvonen PJ; Elfving SM Eur J Clin Pharmacol; 1975 Dec; 9(2-3):213-8. PubMed ID: 1243985 [TBL] [Abstract][Full Text] [Related]
3. Effect of formulation on dissolution and bioavailability of phenytoin tablets. Chakrabarti S; Belpaire F; Moerman E Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745 [TBL] [Abstract][Full Text] [Related]
4. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)]. Brandau R; Wehnert HU Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
7. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation. He Z; Zhong D; Chen X; Liu X; Tang X; Zhao L Eur J Pharm Sci; 2004 Mar; 21(4):487-91. PubMed ID: 14998579 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates. Khan MK; Khan MF; Khan H; Mustafa G Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184 [TBL] [Abstract][Full Text] [Related]
9. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
10. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. Hamaguchi T; Shinkuma D; Irie T; Yamanaka Y; Morita Y; Iwamoto B; Miyoshi K; Mizuno N Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):326-30. PubMed ID: 8370631 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characteristics of some commercial phenobarbital tablets. Sylvestri MF; Ueda CT Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095 [TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate. Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447 [TBL] [Abstract][Full Text] [Related]
14. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets. Babalola CP; Oladimeji FA; Femi-Oyewo MN Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103 [TBL] [Abstract][Full Text] [Related]
15. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets. Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345 [TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Atef E; Belmonte AA Eur J Pharm Sci; 2008 Nov; 35(4):257-63. PubMed ID: 18706499 [TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets. Tulain U; Ur-Rahman N Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443 [TBL] [Abstract][Full Text] [Related]
18. Plasma phenytoin levels produced by various phenytoin preparations. Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data. Khalafalla N; Elgholmy ZA; Khalil SA Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study. Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]